Cleared Traditional

K242922 - Extracorporeal Shock Wave Lithotripter (U200) (FDA 510(k) Clearance)

Class II Gastroenterology & Urology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K242922 · Shenzhen Wikkon Precision Technologies Co., Ltd. · Gastroenterology & Urology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2025
Decision
267d
Days
Class 2
Risk

K242922 is an FDA 510(k) clearance for the Extracorporeal Shock Wave Lithotripter (U200). Classified as Lithotriptor, Extracorporeal Shock-wave, Urological (product code LNS), Class II - Special Controls.

Submitted by Shenzhen Wikkon Precision Technologies Co., Ltd. (Shenzhen, CN). The FDA issued a Cleared decision on June 18, 2025 after a review of 267 days - an extended review cycle.

This device falls under the Gastroenterology & Urology FDA review panel, regulated under 21 CFR 876.5990 - the FDA gastroenterology and urology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Gastroenterology & Urology review framework, consistent with the majority of Class II 510(k) submissions.

View all Shenzhen Wikkon Precision Technologies Co., Ltd. devices

Submission Details

510(k) Number K242922 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 24, 2024
Decision Date June 18, 2025
Days to Decision 267 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
137d slower than avg
Panel avg: 130d · This submission: 267d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LNS Lithotriptor, Extracorporeal Shock-wave, Urological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 876.5990
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Gastroenterology & Urology devices follow this clearance model.

Regulatory Consultant

Qimmiq Medical Consulting Service Co., Ltd.
Yijie You

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - LNS Lithotriptor, Extracorporeal Shock-wave, Urological

All 55
Devices cleared under the same product code (LNS) and FDA review panel - the closest regulatory comparables to K242922.
Break Wave
K261086 · Sonomotion, Inc. · Apr 2026
Break Wave
K252913 · Sonomotion, Inc. · Jan 2026
Delta III Pro
K221903 · Dornier Medtech America, Inc. · Feb 2023
LM-9300 Plus Lithotripter
K213772 · Lite-Med, Inc. · Jan 2023
Modulith SLX-F2
K201001 · Karl Storz Endoscopy America · Mar 2021